You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 14, 2025

Drug Price Trends for GNP COLD MAX DAY-NIGHT CAPLET


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for GNP COLD MAX DAY-NIGHT CAPLET

Average Pharmacy Cost for GNP COLD MAX DAY-NIGHT CAPLET

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
GNP COLD MAX DAY-NIGHT CAPLET 46122-0411-62 0.11501 EACH 2025-01-22
GNP COLD MAX DAY-NIGHT CAPLET 46122-0411-62 0.11601 EACH 2024-12-18
GNP COLD MAX DAY-NIGHT CAPLET 46122-0411-62 0.11417 EACH 2024-11-20
GNP COLD MAX DAY-NIGHT CAPLET 46122-0411-62 0.11950 EACH 2024-10-23
GNP COLD MAX DAY-NIGHT CAPLET 46122-0411-62 0.11607 EACH 2024-09-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for GNP COLD MAX DAY-NIGHT CAPLET

Introduction

The GNP COLD MAX DAY-NIGHT CAPLET is a widely used over-the-counter (OTC) medication designed to provide relief from various symptoms associated with the common cold and flu. This product combines multiple active ingredients, including acetaminophen, chlorpheniramine maleate, dextromethorphan hydrobromide, and phenylephrine hydrochloride, to address pain, fever, cough, nasal congestion, and runny nose.

Market Overview

Global Capsule Cold Medicine Market

The global capsule cold medicine market is experiencing significant growth, driven by the increasing prevalence of colds and respiratory infections, rising consumer awareness about self-care, and the growing availability of OTC cold medicines. By 2033, this market is projected to reach a value of several million USD, expanding at a notable Compound Annual Growth Rate (CAGR)[3].

Segment Dominance

The cough medicine segment, which includes products like GNP COLD MAX DAY-NIGHT CAPLET, holds a substantial share of the market. This is due to the high incidence of cough as a symptom of colds and the increasing availability of OTC cough medicines. The respiratory tract infection segment is also expected to witness robust growth, driven by the rising prevalence of respiratory infections such as bronchitis and pneumonia[3].

Key Ingredients and Mechanism of Action

Active Ingredients

  • Acetaminophen: Acts as a pain reliever and fever reducer.
  • Chlorpheniramine Maleate: An antihistamine that competes with histamine for binding to the H1 receptor, providing relief from runny nose and other allergic symptoms[2][5].
  • Dextromethorphan Hydrobromide: A cough suppressant that acts centrally within the central nervous system to inhibit the transmission of the cough reflex[2].
  • Phenylephrine Hydrochloride: A nasal decongestant that reduces nasal congestion[1][5].

Market Trends

Development of Novel Combination Therapies

The market is seeing a trend towards the development of novel combination therapies that offer broad-spectrum coverage for various cold and flu symptoms. Products like GNP COLD MAX DAY-NIGHT CAPLET, which combine multiple active ingredients, are gaining popularity due to their convenience and effectiveness[3].

Focus on Non-Addictive and Non-Drowsy Formulations

There is a growing demand for non-addictive and non-drowsy formulations, especially among consumers who need to remain alert during the day. This trend is driving the development of new products that avoid sedating ingredients while maintaining efficacy[3].

Increasing Adoption of Telemedicine

The adoption of telemedicine for cold and flu consultations is on the rise, making it easier for consumers to seek medical advice and obtain prescriptions or recommendations for OTC medications like GNP COLD MAX DAY-NIGHT CAPLET[3].

Growth Catalysts

Expansion of Healthcare Coverage

The expansion of healthcare coverage in emerging markets is a significant growth catalyst for the capsule cold medicine market. As more people gain access to healthcare, the demand for effective OTC medications increases[3].

Increased Awareness of Respiratory Health

Growing awareness about respiratory health and the importance of managing cold and flu symptoms effectively is driving the market. Consumers are more inclined to seek out reliable and effective treatments, such as GNP COLD MAX DAY-NIGHT CAPLET[3].

Advancements in Drug Delivery Technologies

Advancements in drug delivery technologies are enhancing the efficacy and convenience of cold medicines. Extended-release formulations, for example, offer extended symptom relief, which is a key feature of many modern cold medications[3].

Price Projections

Current Market Dynamics

The current market for OTC cold medicines is characterized by competition from various brands and formulations. The pricing of GNP COLD MAX DAY-NIGHT CAPLET is influenced by factors such as production costs, market demand, and regulatory environments.

Future Price Trends

Given the expected growth in the global capsule cold medicine market, prices for products like GNP COLD MAX DAY-NIGHT CAPLET may remain stable or see a slight increase. Here are some key factors to consider:

  • Competition: The presence of generic and brand-name competitors can keep prices in check. However, the unique combination of ingredients and the brand reputation of GNP COLD MAX DAY-NIGHT CAPLET may allow for a premium pricing strategy[3].
  • Regulatory Scrutiny: Regulatory changes or restrictions on certain ingredients could impact production costs and, subsequently, prices. However, since GNP COLD MAX DAY-NIGHT CAPLET complies with current regulations, this is less likely to be a significant factor[2][5].
  • Consumer Demand: Increasing consumer demand, driven by the growing awareness of respiratory health and the convenience of combination therapies, could support higher prices[3].

Consumer Preferences

End User Concentration

The market for cold medicines is predominantly driven by mass consumers, with about 80% of the market share. Healthcare professionals also play a role, particularly in recommending OTC medications to patients[3].

Product Preferences

Consumers increasingly prefer non-sedating options to avoid daytime drowsiness. Extended-release formulations and combination therapies are also in high demand due to their convenience and broad-spectrum coverage[3].

Challenges and Opportunities

Market Challenges

  • Competition from Over-the-Counter Nasal Sprays and Non-Drug Remedies: The market faces competition from alternative treatments such as OTC nasal sprays and non-drug remedies like zinc lozenges and homeopathic remedies[3].
  • Generic Competition and Price Pressures: Generic versions of cold medicines can exert price pressure on brand-name products like GNP COLD MAX DAY-NIGHT CAPLET[3].
  • Regulatory Scrutiny: Changes in regulatory policies or restrictions on certain ingredients can impact the market and pricing strategies[2][5].

Opportunities

  • Active Consolidation in the Industry: Large pharmaceutical companies acquiring smaller manufacturers can lead to expanded product portfolios and increased market presence[3].
  • Emerging Markets: The expansion of healthcare coverage in emerging markets presents a significant opportunity for growth[3].

Key Takeaways

  • The global capsule cold medicine market is expected to grow significantly, driven by increasing prevalence of colds, consumer awareness, and advancements in drug delivery technologies.
  • GNP COLD MAX DAY-NIGHT CAPLET benefits from its combination of active ingredients and brand reputation.
  • Price projections suggest stability or a slight increase due to market demand and regulatory compliance.
  • Consumer preferences lean towards non-sedating, extended-release, and combination therapies.
  • The market faces challenges from competition and regulatory scrutiny but offers opportunities in emerging markets and industry consolidation.

FAQs

Q: What are the active ingredients in GNP COLD MAX DAY-NIGHT CAPLET?

A: The active ingredients include acetaminophen, chlorpheniramine maleate, dextromethorphan hydrobromide, and phenylephrine hydrochloride[1][5].

Q: What are the common uses of GNP COLD MAX DAY-NIGHT CAPLET?

A: It is used for relief of head and body aches, fever, sore throat, cough, nasal congestion, and runny nose[1][5].

Q: Can children under 12 years old take GNP COLD MAX DAY-NIGHT CAPLET?

A: Children under 12 years old should consult a doctor before taking this medication[1][5].

Q: What are the potential side effects of GNP COLD MAX DAY-NIGHT CAPLET?

A: Potential side effects include nervousness, dizziness, sleeplessness, and anticholinergic effects such as urinary retention, blurred vision, and dry mouth[2][5].

Q: How does the market trend towards non-addictive and non-drowsy formulations impact GNP COLD MAX DAY-NIGHT CAPLET?

A: This trend may influence the formulation of future versions of the product to avoid sedating ingredients while maintaining efficacy[3].

Sources

  1. DailyMed: COLD MAX NIGHTTIME - acetaminophen, chlorpheniramine maleate, dextromethorphan hydrobromide, and phenylephrine hydrochloride tablet, coated[1].
  2. Texas Health and Human Services: Therapeutic Class Reviews COUGH AND COLD NONNARCOTIC[2].
  3. Data Insights Market: Capsule Cold Medicine Future-Proof Strategies[3].
  4. PubMed: National trends in prescription drug expenditures and projections for 2023[4].
  5. DailyMed: COLD MAX DAY AND NIGHT - acetaminophen, chlorpheniramine maleate, dextromethorphan hydrobromide, and phenylephrine hydrochloride kit[5].

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.